Biofire Technologies is a United States-based startup that is focused on developing advanced firearms technology with the mission of reducing preventable gun injuries and deaths, especially among children. The company's innovative approach and dedication to safety have earned it support from the firearm community, the tech world, and the media. Founded in 2016 by CEO Kai Kloepfer, Biofire has successfully garnered respect and accolades from supporters who believe in the potential of technology to improve firearm safety.
The company's team comprises world-class engineers with diverse backgrounds in designing and testing various cutting-edge technologies, including firearms, medical devices, robotics, and aerospace vehicles. This team's unified commitment to safety and reliability is evident in every aspect of the company's work.
The latest significant development for Biofire is the $7.00M Funding Round investment on 05 February 2024, with participation from notable investors such as Founders Fund, Liquid 2 Ventures, K2 Global, Valhalla Ventures, Umami Capital, Serafund, OPC, CAZ Investments. This investment underlines the confidence and support that Biofire has garnered within the investment community.
As the company continues to push the boundaries of firearms safety technology, it presents an intriguing opportunity for venture capitalists seeking to invest in innovative solutions with the potential for significant societal impact.